Early Detection of Breast Cancer: Symptoms and Screening Methods

Breast cancer is the most common cancer among women worldwide. However, in breast cancer detected at an early stage, treatment options are more numerous, side effects are fewer, and survival rates are significantly higher. What signs should be watched for and how often should screening be performed for early diagnosis in breast cancer? Here is a clinically evidence-based guide.

What Is Early Diagnosis in Breast Cancer?

Early diagnosis in breast cancer means detecting the disease before it has given any symptoms or when the first symptoms appear. Tumours at an early stage are smaller, may not have spread to lymph nodes, and treatment options are wider. According to NCI data, cancers detected by screening mammography have a better prognosis than those diagnosed outside of screening; this is associated with the detection of both early-stage and biologically less aggressive tumours.

The concept of early diagnosis does not only mean “finding it earlier” but also refers to a process that “results in less invasive treatment”. Screening programmes include systematic checks performed at regular intervals for this purpose.

Why Is Early Diagnosis of Vital Importance?

The difference in treatment success between early and advanced-stage breast cancer is dramatic. According to NCI’s breast cancer screening PDQ guidelines, the relative reduction in breast cancer deaths from mammography screening is approximately 1520%. This rate is most pronounced in the 6069 age group; in this age range, screening 377 women can prevent one breast cancer death.

According to data released by the German Federal Office for Radiation Protection in 2025, breast cancer deaths among women who participated in the mammography screening programme during 20092018 decreased by 2030%. This finding demonstrates the concrete effect of regular screening. Additionally, population-based studies in Sweden have reported that screening programmes contribute to a reduction of 1832% in breast cancer deaths.

According to Assoc. Prof. Dr Nilay Şengül, the importance of early diagnosis is critical not only for survival but also for treatment quality: “In clinical practice, breast-conserving surgery (lumpectomy) is possible in the majority of my patients diagnosed with breast cancer that is smaller than 1 centimetre and has no lymph node involvement. Compared with mastectomy (complete removal of the breast), this is a very different process both physically and psychologically. Early diagnosis transforms treatment from ‘fighting cancer’ to ‘managing cancer’.”

Breast Cancer Symptoms: What Should Be Watched For?

According to CDC and NCI data, breast cancer can show different symptoms in everyone; some people may have no symptoms at all. Regular screening is therefore a more reliable method than noticing symptoms. However, symptoms to be aware of include:

As NCI states, breast cancer generally does not cause pain. Pain can result from many non-cancer conditions such as cysts, fibrocystic changes, or hormonal fluctuations. However, persistent pain must always be evaluated.

Assoc. Prof. Dr Şengül highlights a point that patients frequently overlook in clinical practice: “Many patients who come to my clinic wait for weeks saying ‘breast pain is not a sign of cancer’. Yes, pain alone is not a sign of cancer; but if a lump, skin change, or nipple discharge accompanies the pain, this situation should be taken seriously. Particularly unilateral breast pain after menopause should be evaluated more carefully.”

Screening Methods and Recommended Frequency

The main methods used for breast cancer screening are as follows:

• Mammography: Imaging of breast tissue with X-rays. It uses low-dose radiation and is accepted as the gold standard in breast cancer screening. According to NCI data, screening 1,339 women aged 5059 can prevent one breast cancer death; in the 6069 age group this number falls to 377.
• Clinical Breast Examination: A physical examination performed by a health professional. When used together with mammography, sensitivity increases.
• Breast Ultrasound: Used in addition to mammography in women with dense breast tissue. It is useful in differentiating whether masses are cystic (fluid-filled) or solid.
• Magnetic Resonance Imaging (MRI): Recommended in addition to mammography in high-risk women (BRCA1/BRCA2 mutation carriers, those with a strong family history).

According to USPSTF (US Preventive Services Task Force) 2024 recommendations, mammography screening every two years is recommended for women aged 5074. For women aged 4049, the decision should be based on individual risk factors. According to NCI’s AGE Trial data, screening of those aged 4049 did not lead to a statistically significant reduction in breast cancer deaths; however, a temporary benefit was observed over 22.9 years of follow-up.

According to CISNET (Cancer Intervention and Surveillance Modeling Network) modelling, approximately one third of the reduction in breast cancer deaths can be attributed to screening and two thirds to treatment advances. This shows that screening plays an important role in combination with treatment advances, not alone.

Harms of Screening and Informed Decision-Making

As much as the benefits of screening, its potential harms should also be known. According to NCI data, when 10,000 women participate in annual mammography screening for 10 years:

• In a woman aged 50, 332 breast cancer deaths can be prevented.
• In the same group, at least one false-positive result may occur in 6,130 women.
• A false-positive result requiring biopsy may emerge in 940 women.
• Overdiagnosis i.e. detecting a cancer that would not require treatment may occur in 30137 women.

According to Assoc. Prof. Dr Nilay Şengül, these data are important for patients to make informed decisions: “I always tell my patients: Mammography screening is not a ‘guarantee’ but a ‘probability management’ tool. False-positive results can lead to anxiety and unnecessary biopsies; however, the potential for early diagnosis clearly outweighs these risks. What matters is that each woman makes a decision together with her doctor based on her own risk profile.”

Common Misconceptions and Points to Consider

• “Breast cancer always starts with a painful lump”: Incorrect. A significant proportion of breast cancer cases may have no symptoms. A painless lump is more typical, and pain generally results from non-cancer causes.
• “There is no risk without a family history”: Incorrect. Approximately 85% of breast cancer cases occur in women with no family history. Family history increases risk but is not the sole determinant.
• “Self-examination replaces mammography”: Partly incorrect. Self-examination is an awareness tool but is not as sensitive as mammography. Both should be used together.
• “Risk decreases after menopause”: Incorrect. The risk of breast cancer increases with age. The 6069 age group is the age range that benefits most from screening.

Early diagnosis in breast cancer is a critical factor that both increases survival and expands treatment options. When mammography screening, clinical examination, and attention to symptoms are evaluated together, the most effective approach is achieved. Every woman has a different risk profile; therefore the screening decision must be personalised and made together with a doctor.

You can consult Assoc. Prof. Dr Nilay Şengül to evaluate your personal situation regarding early detection of breast cancer and to have your questions answered. To book an appointment at Memorial Şişli Hospital, you can call 444 7 888.